Key result
Review evaluates amiodarone for prophylaxis and rhythm control of postoperative atrial fibrillation after cardiac surgery.
Why the study?
New-onset postoperative atrial fibrillation develops in 10%-50% of patients after cardiac surgery, prompting a review of risk factors and pharmacological prophylaxis with special attention to amiodarone.
Design
Review
Authors
Loading...
Amiodarone reviewed for POAF prophylaxis and control; low-certainty evidence leaves open MI hospitalization benefit.
This review summarizes the risk factors for postoperative atrial fibrillation and the role of amiodarone in its prophylaxis and treatment.
Waterford et al. (2022) conducted a review in Postoperative atrial fibrillation (POAF) after cardiac surgery. Amiodarone was evaluated. Amiodarone is reviewed as a pharmacological strategy for both prophylaxis and rhythm control of postoperative atrial fibrillation, which develops in 10%-50% of patients after cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: